ATE434406T1 - Manganzusammensetzungen und verfahren für mri - Google Patents

Manganzusammensetzungen und verfahren für mri

Info

Publication number: ATE434406T1
Authority: AT; Austria
Prior art keywords: mri; mangale; compositions; methods; source
Prior art date: 1998-11-02

Application number

AT99961531T

Other languages

English (en)

Inventor

Peter Seoane

Phillip Harnish

Adele Vessey

Original Assignee

Eagle Vision Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-02

Filing date

1999-10-26

Publication date

2009-07-15

1999-10-26 Application filed by Eagle Vision Pharmaceutical Co filed Critical Eagle Vision Pharmaceutical Co

2009-07-15 Application granted granted Critical

2009-07-15 Publication of ATE434406T1 publication Critical patent/ATE434406T1/de

Links

239000000203 mixture Substances 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 2
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 1
229910001424 calcium ion Inorganic materials 0.000 abstract 1
239000002872 contrast media Substances 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
229910001437 manganese ion Inorganic materials 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Radiology & Medical Imaging (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Inorganic Compounds Of Heavy Metals (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Magnetic Resonance Imaging Apparatus (AREA)

AT99961531T 1998-11-02 1999-10-26 Manganzusammensetzungen und verfahren für mri ATE434406T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/184,835 US5980863A (en)	1998-11-02	1998-11-02	Manganese compositions and methods for MRI
PCT/US1999/024993 WO2000025671A1 (en)	1998-11-02	1999-10-26	Manganese compositions and methods for mri

Publications (1)

Publication Number	Publication Date
ATE434406T1 true ATE434406T1 (de)	2009-07-15

Family

ID=22678556

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99961531T ATE434406T1 (de)	1998-11-02	1999-10-26	Manganzusammensetzungen und verfahren für mri

Country Status (12)

Country	Link
US (1)	US5980863A (de)
EP (1)	EP1126785B1 (de)
JP (1)	JP4763132B2 (de)
KR (1)	KR100692720B1 (de)
CN (1)	CN1325286A (de)
AT (1)	ATE434406T1 (de)
AU (1)	AU754294B2 (de)
CA (1)	CA2349342C (de)
DE (1)	DE69941029D1 (de)
NO (1)	NO327611B1 (de)
NZ (1)	NZ511592A (de)
WO (1)	WO2000025671A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE373644T1 (de) *	2002-02-05	2007-10-15	Bristol Myers Squibb Co	N-substituierte 3-hydroxy-4-pyridinone und diese enthaltende pharmazeutika
US6869591B2 (en) *	2002-03-26	2005-03-22	Barnes-Jewish Hospital	Paramagnetic particles that provide improved relaxivity
US7966056B2 (en) *	2002-12-16	2011-06-21	Ge Healthcare As	Magnetic resonance imaging method and compounds for use in the method
US20050106100A1 (en) *	2003-09-03	2005-05-19	Harris Thomas D.	Compounds containing matrix metalloproteinase substrates and methods of their use
US20050197614A1 (en) *	2004-03-04	2005-09-08	Wilson Pritchard	Occlusive biomedical devices, punctum plugs, and methods of use thereof
JP2006282604A (ja) *	2005-04-01	2006-10-19	Fuji Photo Film Co Ltd	金属キレート構造を有するグリセリンエステル誘導体
CN101252954A (zh) *	2005-06-30	2008-08-27	布里斯托尔-迈尔斯斯奎布药品公司	作为显像剂的酰肼偶联物
US20080081021A1 (en) *	2006-09-29	2008-04-03	Mehmet Bilgen	Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation
US8414866B2 (en) *	2007-12-17	2013-04-09	Ge Healthcare As	Method of magnetic resonance imaging of the heart with paramagnetic MN2+
WO2011003818A2 (en)	2009-07-06	2011-01-13	Cmc Contrast Ab	Diagnostic method
CN103656690B (zh) *	2012-09-11	2016-04-27	南京逐陆医药科技有限公司	一种氯化锰口服溶液的制备方法
KR101683635B1 (ko)	2014-12-29	2016-12-09	가천대학교 산학협력단	락테이트 금속염을 포함하는 암 치료용 약학 조성물
US10233205B2 (en)	2015-08-07	2019-03-19	Auburn University	Magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide and reducing reactive oxygen species
AU2019206492B2 (en)	2018-01-12	2025-01-09	Metimedi Pharmaceuticals Co., Ltd.	Methods of treating chronic inflammatory diseases
JP2020069470A (ja) *	2018-10-29	2020-05-07	株式会社げんてん本店	リポソームの製造方法、及び、リポソーム含有液の製造方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1965535A (en) *	1933-03-01	1934-07-03	Pfizer Charles & Co	Stable calcium gluconate solution and process of making same
FR2126134A1 (en) *	1971-02-26	1972-10-06	Ates Ibrahim	Cyclophosphamide/magnesium compsns - with enhanced cytostatic activity
US4647447A (en) *	1981-07-24	1987-03-03	Schering Aktiengesellschaft	Diagnostic media
DE3316703A1 (de) *	1983-05-04	1984-11-08	Schering AG, 1000 Berlin und 4709 Bergkamen	Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
SE465907B (sv) *	1984-11-01	1991-11-18	Nyegaard & Co As	Diagnosticeringsmedel innehaallande en paramagnetisk metall
US5082649A (en) *	1987-06-30	1992-01-21	Mallinckrodt Medical, Inc.	Method for enhancing the safety of metal-ligand chelates as magnetic resonance imaging agents by addition of calcium ions
US4915933A (en) *	1986-06-26	1990-04-10	The University Of New Mexico	Mixed complexes as shift and contrast reagents in NMR imaging and spectroscopy
AU608759B2 (en) *	1986-08-04	1991-04-18	Amersham Health Salutar Inc	NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
DK531488A (da) *	1987-09-25	1989-03-26	Salutar Inc	Nmr-billeddannelse med mn(ii)-koordinationsforbindelser
US5078986A (en) *	1989-02-15	1992-01-07	Mallinckrodt Medical, Inc.	Method for enhancing magnetic resonance imaging using an image altering agent containing an excess of chelating agent
US5143716A (en) *	1991-02-01	1992-09-01	Unger Evan C	Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5330742A (en) *	1991-08-05	1994-07-19	Mallinckrodt Medical, Inc.	Methods and compositions for magnetic resonance imaging
US5250284A (en) *	1991-10-15	1993-10-05	Arnon Krongrad	Method for increasing nuclear magnetic resonance signals in living biological tissue using zinc
US5344640A (en) *	1991-10-22	1994-09-06	Mallinckrodt Medical, Inc.	Preparation of apatite particles for medical diagnostic imaging
JP2911674B2 (ja) *	1992-02-20	1999-06-23	明治乳業株式会社	消化管造影用組成物
US5401492A (en) *	1992-12-17	1995-03-28	Sterling Winthrop, Inc.	Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents
GB9416768D0 (en) *	1994-08-18	1994-10-12	Nycomed Innovation Ab	Compositions
CA2197466A1 (en) *	1994-08-18	1996-02-29	Nycomed Imaging A/S	Compositions

1998
- 1998-11-02 US US09/184,835 patent/US5980863A/en not_active Expired - Lifetime
1999
- 1999-10-26 KR KR1020017005278A patent/KR100692720B1/ko not_active Expired - Fee Related
- 1999-10-26 AU AU18086/00A patent/AU754294B2/en not_active Ceased
- 1999-10-26 DE DE69941029T patent/DE69941029D1/de not_active Expired - Lifetime
- 1999-10-26 CN CN99813002A patent/CN1325286A/zh active Pending
- 1999-10-26 CA CA2349342A patent/CA2349342C/en not_active Expired - Fee Related
- 1999-10-26 NZ NZ511592A patent/NZ511592A/xx unknown
- 1999-10-26 EP EP99961531A patent/EP1126785B1/de not_active Expired - Lifetime
- 1999-10-26 AT AT99961531T patent/ATE434406T1/de not_active IP Right Cessation
- 1999-10-26 WO PCT/US1999/024993 patent/WO2000025671A1/en not_active Ceased
- 1999-10-26 JP JP2000579122A patent/JP4763132B2/ja not_active Expired - Fee Related
2001
- 2001-04-19 NO NO20011946A patent/NO327611B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP4763132B2 (ja)	2011-08-31
CN1325286A (zh)	2001-12-05
WO2000025671A9 (en)	2000-10-26
CA2349342C (en)	2011-07-12
EP1126785A1 (de)	2001-08-29
KR20010103622A (ko)	2001-11-23
EP1126785B1 (de)	2009-06-24
KR100692720B1 (ko)	2007-03-09
NO20011946L (no)	2001-04-19
DE69941029D1 (de)	2009-08-06
CA2349342A1 (en)	2000-05-11
AU754294B2 (en)	2002-11-14
US5980863A (en)	1999-11-09
NO327611B1 (no)	2009-08-31
AU1808600A (en)	2000-05-22
JP2002528473A (ja)	2002-09-03
NO20011946D0 (no)	2001-04-19
WO2000025671A1 (en)	2000-05-11
EP1126785A4 (de)	2006-05-17
NZ511592A (en)	2002-09-27

Legal Events

Date	Code	Title	Description
2009-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE434406T1 (de)	2009-07-15	Manganzusammensetzungen und verfahren für mri
DE69431660D1 (de)	2002-12-12	2-pyridylmethylen-polyazamacrocyclophosphonsäuren, ihre komplexe und derivate zur verwendung als kontrastmittel
FI955336A0 (fi)	1995-11-06	Varjoaineina käytettäviä trisyklopolyatsamakrosyklofosfonihappoja, niiden komplekseja ja johdannaisia
BG102729A (bg)	1999-04-30	Метод за дезактивиране на пепел
WO1997044063A3 (en)	1998-02-26	Dha-pharmaceutical agent conjugates
ATE283032T1 (de)	2004-12-15	Formulierungen und verfahren zur verminderung von hautirritationen
BR9815778A (pt)	2001-10-30	Composição nanocompósita de polìmero
DE69430951D1 (de)	2002-08-14	Zusammensetzung enthaltend bradykinin zum selektiven offnen von anormalen gehirngewebes kapillaren
ATE211135T1 (de)	2002-01-15	Aminocyclohexylester und ihre anwendung
DE69433722D1 (de)	2004-05-27	Neue adenosin-monophosphat-deaminase-inhibitoren
ID26395A (id)	2000-12-21	Turunan asam gamma-aminobutirat yang mengandung komposisi padat dan proses pembuatannya
AU4064401A (en)	2001-09-12	Bile acids conjugates with metal ion chelates and the use thereof
WO2000015179A3 (en)	2000-08-03	Cosmetic composition
ATE238814T1 (de)	2003-05-15	Dendrimere fullerenderivate, verfahren zur herstellung und verwendung als neuroprotektiva
MXPA03001643A (es)	2004-05-14	Composiciones y metodos para el diagnostico y tratamiento de tumores.
MX9603602A (es)	1997-05-31	Anticuerpo especifico para fibrina para su uso como agente antitrombotico.
BR9712019A (pt)	1999-08-24	Derivados de cidos hirox-mico citoest ticos
DE50112581D1 (de)	2007-07-19	Verfahren zur Rekonstruktion tieffrequenter Sprachanteile aus mittelhohen Frequenzanteilen
DE69624236D1 (de)	2002-11-14	Ausgewählte lösliche ester von indolcarbazolen die hydroxyl enthalten
WO2002042262A3 (en)	2003-03-27	Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
AU5187698A (en)	1998-06-29	Inhibition of invasive remodelling
GB9425071D0 (en)	1995-02-08	Chondrocyte cell lines
黄宏新 et al.	1995	Quantum Monte Carlo method of localized molecular orbitals
ES2186782T3 (es)	2003-05-16	Uso de derivados de tropolona como inhibidores de la enzima inositol-monofosfatasa.
BR9609724A (pt)	1999-12-21	Composição de limpeza